Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

Urine biomarker for colon cancer?

A molecule detectable in urine may be helpful in diagnosing colon cancer.

Drugs reverse lung cancer cell changes

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.

Obesity genes linked to uterine cancer

In addition to body mass index, genetic markers of obesity may provide value in predicting endometrial cancer risk.

Sosman named to ‘Dream Team’ of cancer investigators